LtaS-IN-2

LtaS-IN-2 (compound 13) is a lipoteichoic acid synthesis inhibitor derived from LtaS-IN-1. It demonstrates potent in vitro antibacterial activity against Staphylococcus species, including S. aureus (MIC90 = 0.5 μg/mL) and S. epidermidis (MIC90 = 1 μg/mL), making it a useful research tool for studying Gram-positive bacterial pathways and anti-infective strategies.